ATRO Medical | Jan Hunik, CEO
ATRO Medical is developing Trammpolin, a prosthetic meniscus made of anatomically shaped polymer for the replacement of damaged menisci.
Entvantage Diagnostics | Joe Skraba, President & CEO
Entvantage Dx is an in-vitro diagnostic company dedicated to reducing antibiotics for ENT illnesses.
Manny Villafaña and Chris Velis Fireside Chat
At LSI USA '22 Emerging Medtech Summit, Life Science Intelligence presented Industry Legend, Manny Villafaña, with the LSI Lifetime Achievement Award in Medical Devices.
Web3, NFTs, and Decentralized Science: The Most Important Topic That You Don't Understand (But Should)
How will Web3, NFTs, and Decentralized Science Impact the future of healthcare?
Yolia Health | Alberto Osio, CEO
True Vision Treatment (TVT) is Yolia Health's two step therapeutic process for the treatment of vision problems like presbyopia and myopia.
Nervonik | Barry Keenan, CEO
Developing a miniaturized neuromodulation device for therapeutic applications.
Surgical Automations | Sanket Chauhan, CEO
Surgical Automations is developing autonomous surgical robots for endoscopic diagnostic and interventional procedures.
SmartBreast | James Hugg, CEO
Molecular breast imaging (MBI) technology to more accurately diagnose early-stage breast cancer in women with dense breast tissue.
Melzi | Reid Rutherford, CEO
Unintended retained foreign object (URFO) is the #1 "never-event" in hospitals. Melzi Sharps Finder helps surgeons inspect the surgical area for metal objects during open, laparoscopic, and robotic surgeries.
Pulsify Medical | Iwan van Vijfeijken, CEO
The Pulsify Patch is intended to offer new insights into patients' cardiovascular health that can't be captured using traditional catheter and ultrasound transducer-based approaches.
New Medtech Incubator Models & Early Stage Investing
This panel will explore how a new model of incubators and early-stage corporate investors are driving innovation.
Medtech M&A and Deal-Making Perspectives
Let's find out directly from major strategics on what deals they are hunting for and hear their outlook on M&A activity in the coming year.
Medtech Venture Investing
Let's dig deep and find out what these VCs are looking for and find out where they are focusing their next round of investments.
Same Goal, Different Paths: CEO Spotlight on Raising Capital
This panel will explore different methods to raise capital and explore why these successful CEOs chose their path. We'll discuss the challenges CEOs in our space experience, and address how those challenges can be overcome.
Strategy: How to Win with Today's IDNs and GPOs
In 2022, how will major providers decide which products meet their needs? How do they decide who wins, and why do so many products never even get an evaluation? What other market trends, nuances, and inside guidance should innovators (and their investors) be thinking about?
After the Capital Raise: Accelerating into Growth Stage
A lively discussion with CEOs that have successfully raised multiple rounds of capital, and now are accelerating into the next stages of growth.
Intelligent/Digital Surgery: Innovation & Opportunities Evolving Rapidly
This panel will explore one of the hottest areas in medtech. Where are we and how far do we have to go? Hear the views of the investor, innovator, and strategic.
Medtech Investing: What VCs Want Right Now
How have recent market dynamics changed the strategies of active medtech VCs? What kind of deals are they looking and what is catching their interest at LSI USA '22?
What Do Strategics Want?
Let's get into it with senior executives from top strategics and find out what kind of deals they are looking for, right now.
Looking through the Loupes: An End User's Perspective
Hear a real-time clinical perspective on the most important takeaways of LSI USA '22 that we should all be paying attention to.
How Leading Medtech Scaleups Are Accelerating Time to Market
This panel gives the different perspectives on how to accelerate time to market from the view of operators, survive providers, and investors.
NXT Medical | Stan Rowe, Co-Founder & CEO
NXT Biomedical is an early stage medical device incubator working to address very large unmet clinical needs including a novel right sided cardiovascular shunt to help patients suffering from pulmonary hypertension and heart failure, as well as a wearable heart failure monitor to help improve patients QOL.
Micro Interventional Devices | Michael Whitman, CEO
Micro Interventional Devices, Inc. (MID) is a development stage medical device company focusing on the design, manufacture and commercialization of disruptive technologies for use in percutaneous structural heart repair procedures.
Veranex | Luis Gutierrez, CCO
Veranex is the only truly comprehensive, global, tech-enabled service provider dedicated to the medical technology industry.
Upending the Medtech Sales Model
In this interactive panel moderated by CEO Scott Carson of MRP, you will hear about the future of the changing Medtech sales landscape and understand the implications it will have on our industry.
The Three I's of Emerging Innovation Ecosystems: Infrastructure, Innovators, Investors
Lets dive into Infrastructure, Innovators, & Investors.
Greenlight Guru | Nick Tippmann, VP of Marketing
Through Greenlight Guru’s turn-key medical device quality management software platform and industry expertise, leading medtech startups are leveraging connected quality in order to launch new devices faster, streamline regulatory compliance and submissions, and scale their business into different markets with ease.